CN102166335A - Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer - Google Patents
Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer Download PDFInfo
- Publication number
- CN102166335A CN102166335A CN2011100794638A CN201110079463A CN102166335A CN 102166335 A CN102166335 A CN 102166335A CN 2011100794638 A CN2011100794638 A CN 2011100794638A CN 201110079463 A CN201110079463 A CN 201110079463A CN 102166335 A CN102166335 A CN 102166335A
- Authority
- CN
- China
- Prior art keywords
- piper longum
- preparation
- soak
- rhizoma zingiberis
- zingiberis recens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 105
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 201000011510 cancer Diseases 0.000 title claims abstract description 23
- 238000002512 chemotherapy Methods 0.000 title claims abstract description 23
- 235000019510 Long pepper Nutrition 0.000 title claims description 73
- 240000003455 Piper longum Species 0.000 title claims description 73
- 235000006886 Zingiber officinale Nutrition 0.000 title claims description 6
- 235000008397 ginger Nutrition 0.000 title claims description 6
- 238000001959 radiotherapy Methods 0.000 title abstract 3
- 231100000419 toxicity Toxicity 0.000 title description 5
- 230000001988 toxicity Effects 0.000 title description 5
- 230000002708 enhancing effect Effects 0.000 title description 3
- 230000001603 reducing effect Effects 0.000 title description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 title 1
- 244000273928 Zingiber officinale Species 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract description 81
- 230000000694 effects Effects 0.000 claims abstract description 41
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000019100 piperine Nutrition 0.000 claims abstract description 34
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 claims abstract description 33
- 229940075559 piperine Drugs 0.000 claims abstract description 33
- 206010047700 Vomiting Diseases 0.000 claims abstract description 26
- 230000008673 vomiting Effects 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 39
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 claims description 37
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 claims description 35
- 235000002780 gingerol Nutrition 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 30
- 238000009835 boiling Methods 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 26
- 238000002481 ethanol extraction Methods 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000012043 crude product Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000002386 leaching Methods 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 241000234314 Zingiber Species 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000010425 asbestos Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000001953 recrystallisation Methods 0.000 claims description 5
- 229910052895 riebeckite Inorganic materials 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000005550 wet granulation Methods 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 241000009298 Trigla lyra Species 0.000 abstract 1
- 239000000469 ethanolic extract Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 14
- 229960004316 cisplatin Drugs 0.000 description 14
- 230000005764 inhibitory process Effects 0.000 description 13
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 229960004397 cyclophosphamide Drugs 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 239000013642 negative control Substances 0.000 description 10
- 241000772415 Neovison vison Species 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 206010039491 Sarcoma Diseases 0.000 description 6
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 229960005343 ondansetron Drugs 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000012449 Kunming mouse Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 231100000053 low toxicity Toxicity 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000758706 Piperaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002464 receptor antagonist Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- MKBLHFILKIKSQM-UHFFFAOYSA-N 9-methyl-3-[(2-methyl-1h-imidazol-3-ium-3-yl)methyl]-2,3-dihydro-1h-carbazol-4-one;chloride Chemical compound Cl.CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 MKBLHFILKIKSQM-UHFFFAOYSA-N 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940041476 lactose 100 mg Drugs 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229960000770 ondansetron hydrochloride Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000019617 piquancy Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种天然药物组合物、其制备方法及其在制备癌症放、化疗中减毒增效药物中的用途，该天然药物组合物由生姜荜拔水煎浓缩提取物、姜辣素、荜拔乙醇提取物与胡椒碱按2-8∶1-4∶2-4∶3-9的比例组成，该组合物对由癌症放、化疗引起的呕吐等副作用有极好的疗效并能同时起到抑制肿瘤的作用。The present invention relates to a natural medicine composition, its preparation method and its application in the preparation of attenuating and synergistic drugs in cancer radiotherapy and chemotherapy. Piper ethanol extract and piperine are composed in the ratio of 2-8:1-4:2-4:3-9, the composition has excellent curative effect on side effects such as vomiting caused by cancer radiotherapy and chemotherapy and can simultaneously play a role in inhibiting tumors.
Description
Technical field
The present invention relates to a kind of natural drug composition, relate more specifically to a kind of natural drug composition of being made up of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine, the preparation method of this natural drug composition and this natural drug composition are being used for preparing the purposes that reduces the vomiting side effect that cancer is put, chemotherapy causes and the treatment cancer is played the medicine of potentiation.
Background technology
Cancer has become the big killer that the mankind face at present, and mortality rate is only second to cardiovascular disease, and is the trend that rises year by year.There is 180 extremely evil property tumor patients every year in China, wherein 2/3 patient accept to put, chemotherapy, though certain curative effect is arranged, put, in various degree side effect can appear in most of patient after the chemotherapy, wherein modal side effect be feel sick, gastrointestinal reaction such as vomiting.Frequent vomiting can cause Digestive system to be lost in a large number, and water, electrolyte, acid base imbalance make patient agonizing, have a strong impact on patient's life quality, not only can have influence on curative effect, even makes patient be difficult to stand and therapy discontinued.
At present, clinical Bendectin commonly used mainly contains histamine (H
2), acetylcholine (M) and dopamine (DA) receptor antagonist and cannabis medicine etc., but the weak curative effect of these medicines, and toxic and side effects is strong, is very limited in the application to putting, vomitting after the chemotherapy.Novel Bendectin is as NK
1Receptor antagonist and 5-HT
3Receptor antagonist class medicine, though to put, the vomiting antiemetic effect is good after the chemotherapy, costs an arm and a leg, the scope of application is narrow, and toxicity is big, clinically needs drug combinations more, and does not see the anticancer synergia effect, the development of the natural anti-cancer attenuation synergistic medicine that therefore waits in expectation.
Chinese medicine for cancer put, the research of chemotherapy attenuation synergistic, attract people's attention.Present still unmatchful anticancer disease is put, chemotherapy has the Chinese patent medicine that alleviates vomiting side effect and potentiation.Therefore, research and develop a kind of high-efficiency low-toxicity, cheap, can be used for of being easy to promote alleviate that cancer is put, emesis of chemotherapy side effect and the natural Chinese medicine that plays the efficacy enhancing and toxicity reducing effect become clinical problem demanding prompt solution.
Chinese medicine Rhizoma Zingiberis Recens (zingiber) is described as " vomiting panacea ".Gingerol is the active ingredient that extracts from Rhizoma Zingiberis Recens, the inventor observe gingerol can resist inorganic and organic poison copper sulfate and cisplatin due to vomit, and suppress the intestinal pheochromocyte and discharge to cause and tell factor 5-HT and P material, gingerol acts on the maximally related NK of emesis of chemotherapy
1And 5-HT
3Deng receptor, be many target spots, natural low toxicity Bendectin.Piper longum is the green fruit of Piperaceae plant Piper longumI., warming spleen and stomach for dispelling cold, therapeutic method to keep the adverse QI flowing downwards pain relieving. can control cholera cold air, vomiting acid regurgitation.In recent years, Rhizoma Zingiberis Recens and Fructus Piperis Longi antitumaous effect are confirmed, and especially Rhizoma Zingiberis Recens piquancy component and Fructus Piperis Longi extract piperine have numerous experiment confirm piperines and have anti-tumor activity, are a kind of natural anti-cancer new drugs that DEVELOPMENT PROSPECT is arranged.The inventor is through research and the experiment and the clinical practice of each a large amount of formula proportion, obtained optimal drug ratio compositions of the present invention at last, it is the compositions of the novelty of agreeing with mutually with polyceptor target spot ratio, and proved that it has fabulous curative effect to the side effect such as vomiting that cancer is put, chemotherapy causes and can play the auxiliary effect that suppresses tumor simultaneously, has finished the present invention thus.
Summary of the invention
First purpose of the present invention is to provide a kind of natural drug composition, and the said composition low toxicity is efficient, determined curative effect, is convenient to use and promotes, both can antitumor, and can resist again and side effect such as put, vomit after the chemotherapy.
Second purpose of the present invention is to provide the preparation method of above-mentioned natural drug composition.
The 3rd purpose of the present invention is to provide that above-mentioned natural drug composition reduces in preparation that cancer is put, chemotherapy side effect and the treatment cancer is played purposes in the medicine of efficacy enhancing and toxicity reducing effect.
A kind of natural drug composition provided by the invention, by Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine by weight in 2-8: the ratio of 1-4: 2-4: 3-9 is formed.
Above-mentioned natural drug composition, wherein the usage ratio of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine is 8: 4: 4: 9.
Wherein, Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction can be by well known to a person skilled in the art the conventional method acquisition of purifying, gingerol and piperine even can commerce buy adopt these compositions that conventional method obtains or the natural drug of the present invention that adopts the commercial one-tenth of buying to be grouped into all can obtain identical curative effect.The method of below listing only is that the inventor thinks preferred method, and is not intended to the extracting method of each composition in this natural drug composition is made special restriction.
Preferably, Rhizoma Zingiberis Recens Piper longum water boiling concentration preparation method of extract is in the above-mentioned natural drug composition:
According to proportion compatibility is 1: 1 or 1-4: 1 other ratios are got Rhizoma Zingiberis Recens, Piper longum, and 10 times of amount distilled water soak 1h, heating decocts 1h on the electric furnace that adds asbestos gauge, silk filters, and preserves filtrate, and medicinal residues add 6 times of distilled water again, soak, decoct, filter with method, twice filtrate is mixed, and heating is concentrated into small size, ultrafiltration membrance filter, adopt 70 ℃ of drying under reduced pressure 36h of vacuum drying oven to get pale brown toner end, be Rhizoma Zingiberis Recens Piper longum water boiling concentration extract.
The preparation method of gingerol is in the above-mentioned natural drug composition:
Rhizoma Zingiberis Recens is thinly sliced, and natural drying breaks into powder with the high speed Universalpulverizer, crosses 30 mesh sieves, and the fine powder that will sieve is again put into the big port grinding bottle of 5000mL, soaks 72h down with 6 times of amount acetone room temperature; At 40 ℃, supersound extraction 15min under the ultrasonic frequency of 40KHz, the centrifugal supernatant that obtains, residue discards; With supernatant decompress filter again, filtrate places the Rotary Evaporators vacuum concentration to get oil of ginger shape mixture, and carrying out this mixture repeatedly again, the concentrate drying purification obtains gingerol.
Piper longum ethanol extraction preparation method is in the above-mentioned natural drug composition:
Get Piper longum, drying is pulverized, and sieves, with 7-10 times of soak with ethanol 12h, cross the leaching clear liquor, residue continues to soak 12h, and twice filtrate is merged centrifugal (3000rpm) 15 minutes, separation of supernatant, water bath method concentrates, and drying under reduced pressure becomes dry extract again, pulverizes, and crosses 100 mesh sieves, promptly.
Process for preparing piperine is in the above-mentioned natural drug composition:
The Piper longum granule is ground into 20 orders,, crosses the leaching clear liquor with 7-10 times of soak with ethanol 12h, residue continues to soak 12h, and twice filtrate is merged, and is evaporated to thick, concentrated solution is put cold place and was left standstill 1-2 days, separates out piperine, filter crude product, exsiccant crude product is dissolved in the ether, and 10%KOH solution washing three times is collected ether layer, boil off ether and get the faint yellow solid powder, the gained powder is dissolved in the ethanol, and the activated carbon decolorizing recrystallization promptly gets the prismatic crystalline piperine of monocline.
The present invention also provides the preferred manufacturing procedure of this natural drug composition, comprising:
(1) preparation of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract
According to proportion compatibility is 1: 1 or 1-4: 1 other ratios are got Rhizoma Zingiberis Recens, Piper longum, and 10 times of amount distilled water soak 1h, heating decocts 1h on the electric furnace that adds asbestos gauge, silk filters, and preserves filtrate, and medicinal residues add 6 times of distilled water again, soak, decoct, filter with method, twice filtrate is mixed, and heating is concentrated into small size, ultrafiltration membrance filter, adopt 70 ℃ of drying under reduced pressure 36h of vacuum drying oven to get pale brown toner end, be Rhizoma Zingiberis Recens Piper longum water boiling concentration extract.
(2) preparation of gingerol
Rhizoma Zingiberis Recens is thinly sliced, and natural drying breaks into powder with the high speed Universalpulverizer, crosses 30 mesh sieves, and the fine powder that will sieve is again put into the big port grinding bottle of 5000mL, soaks 72h down with 6 times of amount acetone room temperature; At 40 ℃, supersound extraction 15min under the ultrasonic frequency of 40KHz; The centrifugal supernatant that obtains, residue discards; With supernatant decompress filter again, filtrate places the Rotary Evaporators vacuum concentration to get oil of ginger shape mixture, and carrying out this mixture repeatedly again, the concentrate drying purification obtains gingerol.
(3) Piper longum ethanol extraction preparation
Get Piper longum, drying is pulverized, and sieves, with 7-10 times of soak with ethanol 12h, cross the leaching clear liquor, residue continues to soak 12h, and twice filtrate is merged centrifugal (3000rpm) 15 minutes, separation of supernatant, water bath method concentrates, and drying under reduced pressure becomes dry extract again, pulverizes, and crosses 100 mesh sieves, promptly.
(4) piperine preparation
The Piper longum granule is ground into 20 orders,, crosses the leaching clear liquor with 7-10 times of soak with ethanol 12h, residue continues to soak 12h, and twice filtrate is merged, and is evaporated to thick, concentrated solution is put cold place and was left standstill 1-2 days, separates out piperine, filter crude product, exsiccant crude product is dissolved in the ether, and 10%KOH solution washing three times is collected ether layer, boil off ether and get the faint yellow solid powder, the gained powder is dissolved in the ethanol, and the activated carbon decolorizing recrystallization promptly gets the prismatic crystalline piperine of monocline.
(5) choose Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine in proportion, uniform mixing, promptly.
The preparation method of above-mentioned natural drug composition, also comprise: the product that step (5) makes is further made the capsule that contains natural drug composition 100mg or 200mg specification by the pharmacy means of routine, maybe will make the tablet that contains natural drug composition 100mg or 200mg specification by wet granulation technology.
The present invention comprises also that natural drug composition reduces in preparation that cancer is put, chemotherapy side effect and the treatment cancer is played purposes in the medicine of potentiation, and reduces the vomiting reaction that cancer is put, chemotherapy causes and the treatment cancer is played purposes in the medicine of potentiation in preparation.
The instructions of taking of natural drug composition of the present invention: the treatment cancer puts, available capsule of vomiting or tablet after the chemotherapy, and 600mg divides three times one after each meal for each person every day.
The beneficial effect of natural drug composition of the present invention aspect resisting emesis and inhibition tumor is as follows:
1, natural drug composition of the present invention has good resisting emesis effect, has now finished clinical preceding pharmaceutical research at mink vomiting model.The mink vomiting model that adopts us to initiate is observed this natural drug composition cisplatin is caused the antagonism over a period to come of mink vomiting model.Studies show that: this natural drug composition has tangible antagonism for the vomiting reaction of mink due to the cisplatin, and its effect is better than using separately Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction.Simultaneously, its reduction causes the rate aspect of vomitting, and its effect matches in excellence or beauty with the Western medicine ondansetron.
2, natural drug composition of the present invention has the effect that suppresses tumor, has now finished clinical preceding pharmaceutical research on mouse tumor model.Adopted mouse tumor model, observed the inhibitory action of natural drug composition mouse interior tumor.Studies show that: this natural drug composition has the obvious suppression effect for mouse interior tumor.
3, proved that in addition this natural drug composition can strengthen the inhibitory action of chemotherapeutics to tumor, now finished clinical preceding pharmaceutical research on the mouse tumor cell model.Adopted mouse tumor model, observed this natural drug composition and cyclophosphamide combined inhibitory action mouse interior tumor.Studies show that: this natural drug composition can obviously increase the inhibitory action of cyclophosphamide for tumor.
4, finished simultaneously in the research of the acute toxicology of mice, studies show that: this natural drug composition does not have influence to feed and behavioral activity etc., and internal organs and pathological observation be no abnormality seen also.Illustrate that this natural drug composition toxicity is very little.
5, the inventor makes up Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine originally, and by the consumption proportion between definite these components of a large amount of experiments, make said composition bring into play good synergism, obtain unexpected effect.Pass through our experimentation repeatedly, make the inventor surprised be ratio between each component of natural drug composition of the present invention at 2-8: 1-4: 2-4: produced unexpected synergism during 3-9, potentiation is obvious, extraordinary effect is played in side effect, especially the usage ratio in each component is 8: 4: 4: 9 o'clock especially obvious, this is that the inventor pays a large amount of creative works by keeping punching and obtains on the paper basis of delivering before, and those of ordinary skills only can't simply obtain this ratio range and optimum amount ratio by disclosed content.
6, this natural drug composition Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and each component of piperine all can obtain by conventional means, some of them component for example gingerol and piperine also can be buied by commerce, and such compositions itself has and obtains convenient, lower-cost effect.This also is the product that has splendid curative effect and higher industrial practicality concurrently that the inventor obtains by a large amount of creative work sides.
The specific embodiment
Further set forth the preparation of natural drug composition of the present invention below by embodiment and test example, with and the beneficial effect in resisting emesis and antitumor, used.
Embodiment
The first step: the preparation of various extracts
(1) preparation of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract
According to proportion compatibility is 1: 1 or 1-4: 1 other ratios are got Rhizoma Zingiberis Recens, Piper longum, and 10 times of amount distilled water soak 1h, heating decocts 1h on the electric furnace that adds asbestos gauge, silk filters, and preserves filtrate, and medicinal residues add 6 times of distilled water again, soak, decoct, filter with method, twice filtrate is mixed, and heating is concentrated into small size, ultrafiltration membrance filter, adopt 70 ℃ of drying under reduced pressure 36h of vacuum drying oven to get pale brown toner end, be Rhizoma Zingiberis Recens Piper longum water boiling concentration extract.
(2) preparation of gingerol
Rhizoma Zingiberis Recens is thinly sliced, and natural drying breaks into powder with the high speed Universalpulverizer, crosses 30 mesh sieves, and the fine powder that will sieve is again put into the big port grinding bottle of 5000mL, soaks 72h down with 6 times of amount acetone room temperature; At 40 ℃, supersound extraction 15min under the ultrasonic frequency of 40KHz; The centrifugal supernatant that obtains, residue discards; With supernatant decompress filter again, filtrate places the Rotary Evaporators vacuum concentration to get oil of ginger shape mixture, and carrying out this mixture repeatedly again, the concentrate drying purification obtains gingerol.
(3) Piper longum ethanol extraction preparation
Get Piper longum, drying is pulverized, and sieves, with 7-10 times of soak with ethanol 12h, cross the leaching clear liquor, residue continues to soak 12h, and twice filtrate is merged centrifugal (3000rpm) 15 minutes, separation of supernatant, water bath method concentrates, and drying under reduced pressure becomes dry extract again, pulverizes, and crosses 100 mesh sieves, promptly.
(4) piperine preparation
The Piper longum granule is ground into 20 orders,, crosses the leaching clear liquor with 7-10 times of soak with ethanol 12h, residue continues to soak 12h, and twice filtrate is merged, and is evaporated to thick, concentrated solution is put cold place and was left standstill 1-2 days, separates out piperine, filter crude product, exsiccant crude product is dissolved in the ether, and 10%KOH solution washing three times is collected ether layer, boil off ether and get the faint yellow solid powder, the gained powder is dissolved in the ethanol, and the activated carbon decolorizing recrystallization promptly gets the prismatic crystalline piperine of monocline.
Second step: the preparation of preparation
(1) preparation of natural drug composition capsule preparations of the present invention
Take by weighing Rhizoma Zingiberis Recens Piper longum water boiling concentration extract 32mg, gingerol 16mg, Piper longum ethanol extraction 16mg and the piperine 36mg of above-mentioned steps preparation respectively, take by weighing starch 395mg, magnesium stearate 5mg simultaneously, uniform mixing, filled capsules is made the capsule of each pure heavy 500mg.
(2) preparation of natural drug composition tablet of the present invention
Take by weighing Rhizoma Zingiberis Recens Piper longum water boiling concentration extract 32mg, gingerol 16mg, Piper longum ethanol extraction 16mg and the piperine 36mg of above-mentioned steps preparation respectively, take by weighing starch 295mg, lactose 100mg simultaneously, uniform mixing, with wet granulation, drying, mix with the 5mg magnesium stearate behind the granulate, tabletting is made the tablet of every pure heavy 500mg.
Drug effect and pharmacology's data:
Compositions is in following test example: the usage ratio of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine is 8: 4: 4: 9.The inventor to above-mentioned each composition usage ratio at 2-8: 1-4: 2-4: the compositions that the multiple proportioning combination in the time of between the 3-9 obtains has been carried out and last identical experiment, find that all the natural drug composition in this amount ranges can obtain good synergism, to cancer put, chemotherapy side effect can play good effect and treatment for cancer is had potentiation.And, the inventor finds that Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine can also be the compositions that obtains with conventional means, and be not only the composition that obtains with above-mentioned method, the compositions that above-mentioned four kinds of one-tenth of buying that made by conventional means or commercial are grouped into has the identical effect of compositions that makes with said method, its experimental data is no longer enumerated here, and those skilled in the art can approve this.Below be drug effect and the pharmacology's data that preferred embodiment obtains:
Test example 1: the pharmacodynamic study of natural drug composition treatment vomiting effect
1, test material
(1) Fructus Piperis Longi is bought by the big pharmacy of Qingdao all living creatures, and Rhizoma Zingiberis Recens is purchased Yushan Hill degree of conquering east, and is accredited as the immature dry fruit of Piperaceae plant Fructus Piperis Longi and the tuber of zingiber by the director of studio of this institute.
(2) cisplatin (cisplatin), Shandong Qilu Pharmaceutical Factory produces, lot number: 903005CE, 20mg/ props up.
(3) Ondansetron Hydrochloride injection, the pharmacy of Olympic Competition health, lot number: 090102,2ml:4mg.
(4) healthy adult mink, body weight 1.3-1.8kg, male, provide by special cultivation animal feeding center, Qingdao, every animal places the ferrum cage of 75cm * 50cm * 50cm separately, 24h natural light irradiation, ad lib drinking-water before the experiment.
2, test method:
Mink is divided into 7 groups at random, every group 6, the A group is the gingerol group, the B group is Piper longum ethanol extraction group, the C group is gingerol and Piper longum ethanol extraction compatibility group (ratio is 1: 1), and the D group is Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, and (Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine were by 8: 4: 4: 9 mixed) for natural drug composition of the present invention for the E group, the F group is the cisplatin positive controls, and the G group is the ondansetron group.The A group is earlier with gingerol 10g.kg
-1(being equivalent to contain the crude drug amount) ig pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip; The B group gives Piper longum ethanol extraction 10g.kg
-1(being equivalent to contain the crude drug amount) ig pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip; The C group gives gingerol and Piper longum ethanol extraction compatibe drug 10g.kg
-1(being equivalent to contain the crude drug amount) ig pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip; The D group gives Rhizoma Zingiberis Recens Piper longum water boiling concentration extract 10g.kg
-1(being equivalent to contain the crude drug amount) ig pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip; The E group gives natural drug composition 10g.kg of the present invention
-1(being equivalent to contain the crude drug amount) ig pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip; The F group gives normal saline, and 30min gives cisplatin 7.5mg.kg
-1Ip; The G group is earlier with ondansetron group 7.5g.kg
-1Pretreatment, 30min gives cisplatin 7.5mg.kg
-1Ip.For observing mink vomiting reaction in the 6h after administration, write down its vomiting incubation period, retch and vomiting number of times.
3, experimental result
Compare with matched group, each treatment group all can obviously alleviate retch and vomiting number of times and prolong vomits incubation period (P＜0.01).Gingerol group, gingerol and Piper longum ethanol extraction compatibility group, Rhizoma Zingiberis Recens Piper longum water boiling concentration extract group reaches natural drug composition of the present invention and can effectively reduce the rate of vomitting that causes, and wherein Rhizoma Zingiberis Recens Piper longum water boiling concentration extract group is identical with the ondansetron group; And causing the rate of vomitting, natural drug composition group of the present invention is lower than the ondansetron group.The results are shown in Table 1.
(7.5mg/kg ip) causes the influence of vomitting and acting on to table 1 extract compatibility to cisplatin
Annotate: a is equivalent to contain the crude drug amount, compares with matched group
cP＜0.01
Test example 2: the pharmacodynamic study of natural drug composition antitumor action of the present invention
1, experiment material
(1) Kunming mouse, body weight 20 ± 2g is provided by Qingdao City medicine inspecting institute Experimental Animal Center.Ad lib drinking-water before the experiment, the 24h natural light irradiation.
(2) cyclophosphamide, the permanent auspicious medical Pharmacy stock Co., Ltd in Jiangsu product.
2, test method:
(1) to mice S
180The inhibition test of sarcoma growth
Employing was gone down to posterity 5-7 days, and well-grown milky ascites is diluted to tumor cell suspension with an amount of physiological saline solution, and cell number is 10
7/ mL, 12 every group, the right axillary fossa subcutaneous vaccination of every Mus 0.2mL (contains oncocyte 2 * 10
6Individual).Inoculation random packet next day, experimental group natural drug composition of the present invention is divided into (400,200,100mg/mL) three dosage groups, every Mus is irritated stomach 0.5ml; Negative control group gives 0.5mL distilled water; The positive drug group gives cyclophosphamide 20gkg
-1D
-1, successive administration 10 days.The conventional raising, drinking-water, food is not limit.Drug withdrawal next day, mice all takes off cervical vertebra puts to death, and strips subcutaneous solid tumor tumor piece, weighs, and calculates tumor control rate (%) by following formula:
Tumor control rate=(the average tumor of the matched group average tumor of heavy (C)-experimental group heavy (T))/average tumor of matched group heavy (C)
(2) to rat liver cancer H
22The inhibition test of growth
Grouping, dosage, administering mode, experimental period and S
180The sarcoma strain is identical.
(3) to the inhibition test of mice ehrlich ascites tumor (solid tumor)
Grouping, dosage, administering mode, experimental period and S
180The sarcoma strain is identical.
3, result of the test
Three dosage groups of natural drug composition of the present invention are to S
180, H
22, EAC and negative control group relatively, inhibitory action is in various degree all arranged, especially the highest to the suppression ratio of tumor with high dose group.(as table 2,3,4)
Table 2 capsule is to S
180The tumor inhibition effect of mice
Compare with negative control group,
cP＜0.01
Table 3 capsule is to H
22The tumor inhibition effect of mice
Compare with negative control group,
bP＜0.01
Table 4 capsule is to the tumor inhibition effect of EAC mice
Compare with negative control group,
bP＜0.05,
cP＜0.01
Test example 3: natural drug composition of the present invention is for the pharmacodynamic study of chemotherapy medicine antitumor potentiation
1, experiment material
(1) Kunming mouse, body weight 20 ± 2g is provided by Qingdao City medicine inspecting institute Experimental Animal Center.Ad lib drinking-water before the experiment, the 24h natural light irradiation.
(2) cyclophosphamide, the permanent auspicious medical Pharmacy stock Co., Ltd in Jiangsu product.
2, test method:
(1) to mice S
180The inhibition test of sarcoma growth
Employing was gone down to posterity 5-7 days, and well-grown milky ascites is diluted to tumor cell suspension with an amount of physiological saline solution, and cell number is 10
7/ mL, 12 every group, the right axillary fossa subcutaneous vaccination of every Mus 0.2ml (contains oncocyte 2 * 10
6Individual).The inoculation next day random packet, experimental group natural drug composition of the present invention is divided into (10,5,2.5gkg
-1) three dosage groups, every Mus is irritated stomach 0.5ml, gives cyclophosphamide 10gkg simultaneously
-1D
-1Negative control group gives 0.5ml distilled water; The positive drug group gives cyclophosphamide 20gkg
-1D
-1, successive administration 10 days.The conventional raising, drinking-water, food is not limit.Drug withdrawal next day, mice all takes off cervical vertebra puts to death, and strips subcutaneous solid tumor tumor piece, weighs, and calculates tumor control rate (%) by following formula:
Tumor control rate=(the average tumor of the matched group average tumor of heavy (C)-experimental group heavy (T))/average tumor of matched group heavy (C)
(2) to rat liver cancer H
22The inhibition test of growth
Grouping, dosage, administering mode, experimental period and S
180The sarcoma strain is identical.
(3) to the inhibition test of mice ehrlich ascites tumor (solid tumor)
Grouping, dosage, administering mode, experimental period and S
180The sarcoma strain is identical.
3, result of the test
Under the situation that reduces the cyclophosphamide dosage, three dosage of natural drug composition of the present invention and cyclophosphamide combined medication group are to S
180, H
22, EAC and negative control group relatively, inhibitory action is in various degree all arranged, especially the highest to the suppression ratio of tumor with high dose group.(as table 5,6,7)
Table 5 capsule is to S
180The tumor inhibition effect of mice
Compare with negative control group,
bP＜0.05,
cP＜0.01
Compatibility drug group height: cyclophosphamide 10gkg
-1+ compositions 10gkg
-1In the compatibility drug group: cyclophosphamide 10gkg
-1+ compositions 5gkg
-1The compatibility drug group is low: cyclophosphamide 10gkg
-1+ compositions 2.5gkg
-1, down together
Table 6 capsule is to H
22The tumor inhibition effect of mice
Compare with negative control group,
bP＜0.05,
cP＜0.01
Table 7 capsule is to the tumor inhibition effect of EAC mice
Compare with negative control group,
bP＜0.05,
cP＜0.01
Test example 4: the acute toxicity test of natural drug composition of the present invention
1, experimental animal:
Kunming mouse, body weight 20 ± 2g is provided by Qingdao City medicine inspecting institute Experimental Animal Center
2, medicine:
Natural drug composition of the present invention, tragakanta
3, test method:
According to " the study of tcm new drug specification requirement " of National Drug Administration's promulgation in one on November 12, in 999 revision, natural drug of the present invention is carried out acute toxicity testing.Because of being subjected to drug level and volume restrictions, can't measure LD
50So, carry out the maximum dosage-feeding experiment.Get 30 of Kunming mouses, female half and half, ig gives capsule Chinese medicine 1g/mL, every 0.8mL, and it is long-pending that promptly the maximum of mice is irritated body of stomach, observes mice active state, diet, feces, breathing, body weight and death condition after the medication, observes 14d. continuously
4, result of the test:
Each organizes well-grown after the mouse stomach administration, weight increase, and behavior is normal, there is no death and significant reaction.Behind sacrifice of animal, the no abnormal phenomenon of each main organs of perusal.
The result shows that natural drug composition maximal dose oral application of the present invention does not have obvious damage to animal, does not find the toxic reaction to the body generation, is a kind of safe and reliable medicine.
Claims (7)
1. natural drug composition, it is characterized in that said composition by Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine by weight in 2-8: the ratio of 1-4: 2-4: 3-9 is formed,
Wherein Rhizoma Zingiberis Recens Piper longum water boiling concentration preparation method of extract is:
According to proportion compatibility is 1: 1 or 1-4: 1 other ratios are got Rhizoma Zingiberis Recens, Piper longum, and 10 times of amount distilled water soak 1h, heating decocts 1h on the electric furnace that adds asbestos gauge, silk filters, and preserves filtrate, and medicinal residues add 6 times of distilled water again, soak, decoct, filter with method, twice filtrate is mixed, and heating is concentrated into small size, ultrafiltration membrance filter, adopt 70 ℃ of drying under reduced pressure 36h of vacuum drying oven to get pale brown toner end, be Rhizoma Zingiberis Recens Piper longum water boiling concentration extract.
Wherein the preparation method of Piper longum ethanol extraction is:
Get Piper longum, drying is pulverized, and sieves, with 7-10 times of soak with ethanol 12h, cross the leaching clear liquor, residue continues to soak 12h, and twice filtrate is merged centrifugal (3000rpm) 15 minutes, separation of supernatant, water bath method concentrates, and drying under reduced pressure becomes dry extract again, pulverizes, and crosses 100 mesh sieves, promptly.
Wherein the preparation method of piperine is:
The Piper longum granule is ground into 20 orders,, crosses the leaching clear liquor with 7-10 times of soak with ethanol 12h, residue continues to soak 12h, and twice filtrate is merged, and is evaporated to thick, concentrated solution is put cold place and was left standstill 1-2 days, separates out piperine, filter crude product, exsiccant crude product is dissolved in the ether, and 10%KOH solution washing three times is collected ether layer, boil off ether and get the faint yellow solid powder, the gained powder is dissolved in the ethanol, and the activated carbon decolorizing recrystallization promptly gets the prismatic crystalline piperine of monocline.
2. natural drug composition as claimed in claim 1, wherein the usage ratio of Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine is 8: 4: 4: 9.
3. natural drug composition as claimed in claim 1, wherein the preparation method of gingerol is:
Rhizoma Zingiberis Recens is thinly sliced, and natural drying breaks into powder with the high speed Universalpulverizer, crosses 30 mesh sieves, and the fine powder that will sieve is again put into the big port grinding bottle of 5000mL, to soak 72h under the alcohol at normal temperature of 6 times of amounts 95%; At 40 ℃, supersound extraction 15min under the ultrasonic frequency of 40KHz, the centrifugal supernatant that obtains, residue discards; With supernatant decompress filter again, filtrate places the Rotary Evaporators vacuum concentration to get oil of ginger shape mixture, and carrying out this mixture repeatedly again, the concentrate drying purification obtains gingerol.
4. as the preparation method of the natural drug composition of claim 1 or 2, it is characterized in that this method comprises:
(1) Rhizoma Zingiberis Recens Piper longum water boiling concentration extract preparation
According to proportion compatibility is 1: 1 or 1-4: 1 other ratios are got Rhizoma Zingiberis Recens, Piper longum, and 10 times of amount distilled water soak 1h, heating decocts 1h on the electric furnace that adds asbestos gauge, silk filters, and preserves filtrate, and medicinal residues add 6 times of distilled water again, soak, decoct, filter with method, twice filtrate is mixed, and heating is concentrated into small size, ultrafiltration membrance filter, adopt 70 ℃ of drying under reduced pressure 36h of vacuum drying oven to get pale brown toner end, be Rhizoma Zingiberis Recens Piper longum water boiling concentration extract.
(2) gingerol preparation
Rhizoma Zingiberis Recens is thinly sliced, and natural drying breaks into powder with the high speed Universalpulverizer, crosses 30 mesh sieves, and the fine powder that will sieve is again put into the big port grinding bottle of 5000mL, to soak 72h under the alcohol at normal temperature of 6 times of amounts 95%; At 40 ℃, supersound extraction 15min under the ultrasonic frequency of 40KHz, the centrifugal supernatant that obtains, residue discards; With supernatant decompress filter again, filtrate places the Rotary Evaporators vacuum concentration to get oil of ginger shape mixture, and carrying out this mixture repeatedly again, the concentrate drying purification obtains gingerol.
(3) Piper longum ethanol extraction preparation
Get Piper longum, drying is pulverized, and sieves, with 7-10 times of soak with ethanol 12h, cross the leaching clear liquor, residue continues to soak 12h, and twice filtrate is merged centrifugal (3000rpm) 15 minutes, separation of supernatant, water bath method concentrates, and drying under reduced pressure becomes dry extract again, pulverizes, and crosses 100 mesh sieves, promptly.
(4) piperine preparation
The Piper longum granule is ground into 20 orders,, crosses the leaching clear liquor with 7-10 times of soak with ethanol 12h, residue continues to soak 12h, and twice filtrate is merged, and is evaporated to thick, concentrated solution is put cold place and was left standstill 1-2 days, separates out piperine, filter crude product, exsiccant crude product is dissolved in the ether, and 10%KOH solution washing three times is collected ether layer, boil off ether and get the faint yellow solid powder, the gained powder is dissolved in the ethanol, and the activated carbon decolorizing recrystallization promptly gets the prismatic crystalline piperine of monocline.
(5) choose Rhizoma Zingiberis Recens Piper longum water boiling concentration extract, gingerol, Piper longum ethanol extraction and piperine uniform mixing in proportion, promptly.
5. as the preparation method of claims 4 described natural drug compositions, also comprise: the product that step (5) makes is further made the capsule that contains natural drug composition 100mg or 200mg specification by the pharmacy means of routine, maybe will make the tablet that contains natural drug composition 100mg or 200mg specification by wet granulation technology.
As each described natural drug composition of claim 1-3 reduce in preparation that cancer is put, chemotherapy side effect and the treatment cancer is played purposes in the medicine of potentiation.
7. as the purposes of each described natural drug composition of claim 1-3 in preparing the medicine that reduces the vomiting reaction that cancer is put, chemotherapy causes and the treatment cancer is played potentiation.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100794638A CN102166335A (en) | 2011-03-31 | 2011-03-31 | Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| CN 201210014629 CN102526666B (en) | 2011-03-31 | 2012-01-10 | Ginger-long pepper composition of for reducing vomit caused by cancer chemotherapy and enhancing chemotherapy effect and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100794638A CN102166335A (en) | 2011-03-31 | 2011-03-31 | Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102166335A true CN102166335A (en) | 2011-08-31 |
Family
ID=44487777
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100794638A Withdrawn CN102166335A (en) | 2011-03-31 | 2011-03-31 | Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| CN 201210014629 Expired - Fee Related CN102526666B (en) | 2011-03-31 | 2012-01-10 | Ginger-long pepper composition of for reducing vomit caused by cancer chemotherapy and enhancing chemotherapy effect and preparation method thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210014629 Expired - Fee Related CN102526666B (en) | 2011-03-31 | 2012-01-10 | Ginger-long pepper composition of for reducing vomit caused by cancer chemotherapy and enhancing chemotherapy effect and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN102166335A (en) |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103012095A (en) * | 2012-12-06 | 2013-04-03 | 山东农业大学 | Method for combined extraction of variety of functional components of ginger |
| CN103182006A (en) * | 2013-03-27 | 2013-07-03 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103181959A (en) * | 2013-03-27 | 2013-07-03 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103191193A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine extract and preparation method thereof |
| CN103191179A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine extract and preparation method thereof |
| CN103191194A (en) * | 2013-03-29 | 2013-07-10 | 阚兆云 | Traditional chinese medicine extract and preparation method thereof |
| CN103191201A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103202869A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103202898A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103202886A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103251706A (en) * | 2013-04-08 | 2013-08-21 | 张宗升 | Traditional chinese medicine composition |
| CN103263493A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional Chinese medicine composition and preparation method thereof |
| CN103263499A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional chinese medicine extract |
| CN103263490A (en) * | 2013-03-29 | 2013-08-28 | 阚兆云 | Extract from traditional Chinese medicine and its preparation method |
| CN103263500A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional Chinese medicine extract and preparation method thereof |
| CN103272021A (en) * | 2013-03-29 | 2013-09-04 | 阚兆云 | Traditional chinese medicine extract |
| CN103301207A (en) * | 2013-06-30 | 2013-09-18 | 石强 | Natural drug composition, preparation method and use thereof |
| CN103330787A (en) * | 2013-07-19 | 2013-10-02 | 石强 | Natural medicine extractive |
| CN103330894A (en) * | 2013-03-29 | 2013-10-02 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103340934A (en) * | 2013-07-19 | 2013-10-09 | 石强 | Natural medicament composition |
| CN103340935A (en) * | 2013-06-30 | 2013-10-09 | 石强 | Chinese medicine composition and preparation method thereof |
| CN103349680A (en) * | 2013-07-20 | 2013-10-16 | 石强 | Natural pharmaceutical extractive |
| CN103356778A (en) * | 2013-07-02 | 2013-10-23 | 石强 | Traditional chinese medicine composition |
| CN105188400A (en) * | 2013-03-15 | 2015-12-23 | 爱默思公司 | Compositions and methods for preventing, alleviating, alleviating or treating idiopathic emesis |
| US10441623B2 (en) | 2013-03-15 | 2019-10-15 | Mars, Incorporated | Dietary composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393765A (en) * | 2013-07-20 | 2013-11-20 | 石强 | Natural pharmaceutical composition and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1321679C (en) * | 2005-05-20 | 2007-06-20 | 广州中医药大学 | Ginger and dried orange peel extracts mixture for treating cardiovascular disease |
| CN101264311B (en) * | 2008-04-21 | 2010-08-25 | 青岛大学 | Natural pharmaceutical composition, its preparation and its attenuation synergistic use in cancer radiotherapy and chemotherapy |
-
2011
- 2011-03-31 CN CN2011100794638A patent/CN102166335A/en not_active Withdrawn
-
2012
- 2012-01-10 CN CN 201210014629 patent/CN102526666B/en not_active Expired - Fee Related
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103012095B (en) * | 2012-12-06 | 2014-07-30 | 山东农业大学 | Method for combined extraction of variety of functional components of ginger |
| CN103012095A (en) * | 2012-12-06 | 2013-04-03 | 山东农业大学 | Method for combined extraction of variety of functional components of ginger |
| US11419912B2 (en) | 2013-03-15 | 2022-08-23 | Mars, Incorporated | Dietary composition for preventing, reducing, alleviating or treating idiopathic vomiting |
| CN105188400A (en) * | 2013-03-15 | 2015-12-23 | 爱默思公司 | Compositions and methods for preventing, alleviating, alleviating or treating idiopathic emesis |
| US10441623B2 (en) | 2013-03-15 | 2019-10-15 | Mars, Incorporated | Dietary composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
| US10548935B2 (en) | 2013-03-15 | 2020-02-04 | Mars, Incorporated | Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting |
| CN105188400B (en) * | 2013-03-15 | 2024-04-05 | 马斯公司 | Compositions and methods for preventing, alleviating, relieving or treating idiopathic vomiting |
| CN103182006A (en) * | 2013-03-27 | 2013-07-03 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103181959A (en) * | 2013-03-27 | 2013-07-03 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103191193A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine extract and preparation method thereof |
| CN103191179A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine extract and preparation method thereof |
| CN103191201A (en) * | 2013-03-27 | 2013-07-10 | 张宗升 | Traditional chinese medicine composition and preparation method thereof |
| CN103272021A (en) * | 2013-03-29 | 2013-09-04 | 阚兆云 | Traditional chinese medicine extract |
| CN103263490A (en) * | 2013-03-29 | 2013-08-28 | 阚兆云 | Extract from traditional Chinese medicine and its preparation method |
| CN103202898B (en) * | 2013-03-29 | 2014-04-16 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103202886A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103202898A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103330894A (en) * | 2013-03-29 | 2013-10-02 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103202869A (en) * | 2013-03-29 | 2013-07-17 | 阚兆云 | Traditional chinese medicine composition and preparation method thereof |
| CN103191194A (en) * | 2013-03-29 | 2013-07-10 | 阚兆云 | Traditional chinese medicine extract and preparation method thereof |
| CN103251706A (en) * | 2013-04-08 | 2013-08-21 | 张宗升 | Traditional chinese medicine composition |
| CN103263500A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional Chinese medicine extract and preparation method thereof |
| CN103263499A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional chinese medicine extract |
| CN103263493A (en) * | 2013-04-16 | 2013-08-28 | 阚兆云 | Traditional Chinese medicine composition and preparation method thereof |
| CN103340935A (en) * | 2013-06-30 | 2013-10-09 | 石强 | Chinese medicine composition and preparation method thereof |
| CN103301207A (en) * | 2013-06-30 | 2013-09-18 | 石强 | Natural drug composition, preparation method and use thereof |
| CN103356778A (en) * | 2013-07-02 | 2013-10-23 | 石强 | Traditional chinese medicine composition |
| CN103340934A (en) * | 2013-07-19 | 2013-10-09 | 石强 | Natural medicament composition |
| CN103330787A (en) * | 2013-07-19 | 2013-10-02 | 石强 | Natural medicine extractive |
| CN103349680A (en) * | 2013-07-20 | 2013-10-16 | 石强 | Natural pharmaceutical extractive |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526666B (en) | 2013-08-21 |
| CN102526666A (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102166335A (en) | Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer | |
| CN102133384B (en) | Ginger and dried orange peel composition, preparation method thereof and application of ginger and dried orange peel composition in preparation of attenuated synergistic medicaments in cancer radiotherapy and chemotherapy | |
| CN102145158A (en) | Ginger and clove composition, preparation method of ginger and clove composition and use of ginger and clove composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy | |
| CN102166338B (en) | Composition of cardamom and ginger, its preparation method and its use in the preparation of drugs with attenuated toxicity and enhanced efficacy in cancer radiotherapy and chemotherapy | |
| CN102091315B (en) | Ginger and dark plum composition, preparation method thereof and application thereof in preparation of toxicity-reducing and efficacy-enhancing medicines in cancer radiotherapy and chemotherapy | |
| CN102145159A (en) | Ginger and elecampane composition, preparation method of ginger and elecampane composition and use of ginger and elecampane composition for preparing toxicity-reducing efficacy-improving medicine in cancer radiotherapy and chemotherapy | |
| CN102091314B (en) | Dried ginger and Evodia rutaecarpa composition, its preparation method and its use in the preparation of drugs with attenuated toxicity and enhanced efficacy in cancer radiotherapy and chemotherapy | |
| CN102133385A (en) | Ginger and white pepper composition, preparation method thereof and application thereof to preparation of medicaments for attenuation and synergia in cancer radiochemotherapy | |
| CN103191201A (en) | Traditional chinese medicine composition and preparation method thereof | |
| CN103239636A (en) | Application of reed rhizome extract and gingerol in preparation of attenuated synergistic medicines for cancer chemotherapy | |
| CN102166336A (en) | Composition of loguat leaves and ginger as well as preparation method and application thereof to preparing toxicity reducing and efficacy enhancing medicines for radiotherapy and chemotherapy of cancers | |
| CN102091313B (en) | Perilla leaf and ginger composition, its preparation method and its use in the preparation of cancer radiotherapy and chemotherapy drugs | |
| CN102091312B (en) | Ginger and Zanthoxylum bungeanum composition, its preparation method and its use in the preparation of drugs with attenuated toxicity and enhanced efficacy in cancer radiotherapy and chemotherapy | |
| CN102166337A (en) | Ginger and inula flower composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer | |
| CN103202898A (en) | Traditional chinese medicine composition and preparation method thereof | |
| CN103263475A (en) | Traditional chinese medicine composition | |
| CN103263492A (en) | Traditional chinese medicine extract | |
| CN103316088A (en) | Natural pharmaceutical composition | |
| CN102133383B (en) | Composition of ginger and bergamot, its preparation method and its use in the preparation of drugs with attenuated toxicity and enhanced efficacy in cancer radiotherapy and chemotherapy | |
| CN103202886A (en) | Traditional chinese medicine composition and preparation method thereof | |
| CN102552848A (en) | Ginger and kudzuvine root composition for reducing vomiting caused by cancer chemotherapy and improving chemotherapy effects, and preparation method for ginger and kudzuvine root composition | |
| CN103263503A (en) | Traditional chinese medicine extract | |
| CN103263474A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN111973726A (en) | Ginger mango drug pair for inhibiting chemotherapy and postoperative vomiting and preparation method thereof | |
| CN103223135A (en) | Traditional chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Open date: 20110914 |